Elizabeth M Mandel-Bausch

Title: Innovator Spotlight: Elizabeth M. Mandel-Bausch

Introduction

Elizabeth M. Mandel-Bausch is a distinguished inventor based in Milford, Connecticut. With an impressive portfolio comprising seven patents, she has made significant contributions to the field of biotechnology, particularly in the area of antibody development. Her work focuses on creating innovative solutions for diagnosing and treating KIT-associated disorders.

Latest Patents

One of her latest patents, titled "Anti-KIT antibodies and uses thereof," offers groundbreaking methods for targeting human KIT antigens. This invention details antibodies that specifically bind to the fourth and/or fifth extracellular Ig-like domains of the KIT antigen, known as D4 and D5 domains. Furthermore, these antibodies possess the ability to inhibit KIT activity, which is crucial for receptor phosphorylation induced by ligands. Moreover, the patent covers kits and pharmaceutical compositions formulated with these antibodies, as well as methods for diagnosing and treating KIT-associated conditions.

Career Highlights

Elizabeth has worked with notable companies such as Celldex Therapeutics Limited and Kolltan Pharmaceuticals, Inc. throughout her career. Her expertise in the field of immunology and biotechnology has propelled her to the forefront of innovation.

Collaborations

During her professional journey, Elizabeth has collaborated with esteemed colleagues, including Yaron R. Hadari and Francis Joseph Carr. These partnerships have bolstered the scope and impact of her research.

Conclusion

Through her relentless pursuit of innovation and her dedication to advancing medical science, Elizabeth M. Mandel-Bausch has established herself as a notable figure in the field of antibody research. Her contributions pave the way for new therapeutic approaches to treating KIT-associated disorders, reflecting the importance of innovation in healthcare.